Translational control of gene expression and disease

被引:74
作者
Calkhoven, CF [1 ]
Müller, C [1 ]
Leutz, A [1 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
关键词
D O I
10.1016/S1471-4914(02)02424-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the past decade, translational control has been shown to be crucial in the regulation of gene expression. Research in this field has progressed rapidly, revealing new control mechanisms and adding constantly to the list of translationally regulated genes. There is accumulating evidence that translational control plays a primary role in cell-cycle progression and cell differentiation, as well as in the induction of specific cellular functions. Recently, the aetiologies of several human diseases have been linked with mutations in genes of the translational control machinery, highlighting the significance of this regulatory mechanism. In addition, deregulation of translation is associated with a wide range of cancers. Current research focuses on novel therapeutic strategies that target translational control, a promising concept in the treatment of human diseases.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 65 条
[41]  
Louro ID, 1999, CELL GROWTH DIFFER, V10, P503
[42]   PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond [J].
Marte, BM ;
Downward, J .
TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (09) :355-358
[43]   Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR [J].
Neshat, MS ;
Mellinghoff, IK ;
Tran, C ;
Stiles, B ;
Thomas, G ;
Petersen, R ;
Frost, P ;
Gibbons, JJ ;
Wu, H ;
Sawyers, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10314-10319
[44]   Functions of the fragile X protein [J].
Oostra, BA .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (03) :102-103
[45]   CCAAT ENHANCER-BINDING PROTEIN MESSENGER-RNA IS TRANSLATED INTO MULTIPLE PROTEINS WITH DIFFERENT TRANSCRIPTION ACTIVATION POTENTIALS [J].
OSSIPOW, V ;
DESCOMBES, P ;
SCHIBLER, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8219-8223
[46]  
Palakurthi SS, 2000, CANCER RES, V60, P2919
[47]  
Palakurthi SS, 2001, CANCER RES, V61, P6213
[48]   BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2 [J].
Perrotti, D ;
Cesi, V ;
Trotta, R ;
Guerzoni, C ;
Santilli, G ;
Campbell, K ;
Iervolino, A ;
Condorelli, F ;
Gambacorti-Passerini, C ;
Caligiuri, MA ;
Calabretta, B .
NATURE GENETICS, 2002, 30 (01) :48-58
[49]   E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo [J].
Porse, BT ;
Pedersen, TÅ ;
Xu, XF ;
Lindberg, B ;
Wewer, UM ;
Friis-Hansen, L ;
Nerlov, C .
CELL, 2001, 107 (02) :247-258
[50]  
Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.0.CO